Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Sales: 2020-2025

Historic Return on Sales for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to -1.11%.

  • Maravai Lifesciences Holdings' Return on Sales rose 6.00% to -1.11% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.11%, marking a year-over-year increase of 6.00%. This contributed to the annual value of -1.00% for FY2024, which is 52.00% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Return on Sales of -1.11% as of Q3 2025, which was up 28.42% from -1.55% recorded in Q2 2025.
  • Maravai Lifesciences Holdings' Return on Sales' 5-year high stood at 0.61% during Q2 2022, with a 5-year trough of -1.55% in Q2 2025.
  • Moreover, its 3-year median value for Return on Sales was -0.61% (2024), whereas its average is -0.61%.
  • In the last 5 years, Maravai Lifesciences Holdings' Return on Sales spiked by 31bps in 2021 and then tumbled by 131bps in 2024.
  • Maravai Lifesciences Holdings' Return on Sales (Quarterly) stood at 0.59% in 2021, then fell by 3bps to 0.56% in 2022, then tumbled by 103bps to -0.48% in 2023, then slumped by 52bps to -1.00% in 2024, then rose by 6bps to -1.11% in 2025.
  • Its Return on Sales was -1.11% in Q3 2025, compared to -1.55% in Q2 2025 and -1.20% in Q1 2025.